IL6R and glioblastoma: Moreover, Kammerer and co-workers observed significant upregulation of inflammation-related genes, including CXCL2, CXCL3, IL1A, and IL6 receptor (IL6R)) after non-lethal 5-ALA-PDT in a panel of prostate and glioblastoma cell lines [33].